For the year ending 2025-12-31, QTTB made $53,737K in revenue. $29,821K in net income. Net profit margin of 55.49%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration arrangement revenue | 53,737 | |||
| Research and development | 19,156 | |||
| General and administrative | 17,679 | |||
| Total operating expenses | 36,835 | |||
| Income (loss) from operations | 16,902 | |||
| Change in fair value of convertible notes | 0 | |||
| Gain on sale of asset | 11,737 | |||
| Other income (expense), net | 1,182 | |||
| Total other income (expense), net | 12,919 | |||
| Income (loss) before provision for income taxes and loss from equity method investment | 29,821 | |||
| Provision for income taxes | 0 | |||
| Loss from equity method investment | 0 | |||
| Net income (loss) | 29,821 | |||
| Basic EPS | 2.42 | |||
| Diluted EPS | 2.42 | |||
| Basic Average Shares | 12,300,568 | |||
| Diluted Average Shares | 12,314,796 | |||
Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB)